Return to content in this issue

 

H1-antihistamines may be no longer necessary for patients with refractory chronic spontaneous urticaria after introduction of omalizumab treatment

Ensina LF1,2, Arruda LK3, Campos RA4, Criado RFJ5, Valle SOR6, Melo JML3, Oliveira JCS4, Dortas-Junior SD6, Cusato-Ensina AP1, Camelo Nunes IC2, Agondi RC7

1CPAlpha Clinical Research Center
2Federal University of São Paulo
3RibeirãoPreto Medical School, University of São Paulo
4Federal University of Bahia
5Faculdade de Medicina do ABC
6Federal Universityof Rio de Janeiro
7Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo

J Investig Allergol Clin Immunol 2020; Vol. 30(2)
doi: 10.18176/jiaci.0464

Key words: Urticaria, Therapeutics, Omalizumab, Histamineantagonists

Title Type Size
19-00256-supplementarytable.pdf pdf 447.58 Kb